Skip to main content
PRCT logo

PRCT

PROCEPT BioRobotics Corp
$20.89 +1.14 (+5.77%) At close · Jul 10
Market Cap
$1.19B
Shares
56,918,844

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$308.05M +37.2%
FY2025 Revenue FY2020–FY2025
Net Income
-$95.57M -4.5%
FY2025 Net Income FY2020–FY2025
Gross Margin
63.7% +2.6pp
FY2025 Gross Margin FY2020–FY2025
Operating Margin
-33.71% +9.3pp
FY2025 Operating Margin FY2020–FY2025
Diluted EPS
-$1.72 +1.7%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$48.99M +50.6%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
$390M – $410M $322.02M $308.05M $224.5M $136.19M $75.01M $34.47M $7.72M
$116.01M $111.83M $87.4M $65.14M $37.93M $18.61M $8.97M
$206.01M $196.23M $137.1M $71.05M $37.09M $15.87M -$1.26M
63.7% 61.07% 52.17% 49.44% 46.02% -16.26%
$76.34M $71.28M $62.3M $48.45M $28.98M $18.99M $16.28M
$238.7M $228.81M $171.42M $131.77M $88.83M $51.04M $30.27M
$300K $300K $300K $300K $300K $300K
$6.39M $5.23M $3.81M $2.84M $3.32M $2.86M
$315.04M $300.09M $233.71M $180.22M $117.81M $70.03M $46.55M
-$109.03M -$103.86M -$96.61M -$109.17M -$80.72M -$54.16M -$47.8M
-33.71% -43.04% -80.16% -107.61% -157.12% -619.44%
-$97.47M -$91.38M -$105.36M -$77.88M -$50.84M -$44.94M
$3.53M $3.59M $4.18M $4M $5.18M $5.81M $5.26M
$12.22M $10.9M $7.55M $2.5M $76K $184K
-$156K -$1.03M -$96K -$203K -$154K -$25K
-$95.38M -$91.05M -$105.82M
$190K $368K $80K $0 $0 $0
-$102.47M -$95.57M -$91.41M -$105.9M -$87.15M -$59.85M -$53.02M
-31.02% -40.72% -77.76% -116.18% -173.62% -687.04%
-$102.72M -$95.65M -$91.38M -$105.81M -$87.11M -$59.89M -$53.04M
USD/shares -$1.72 -$1.75 -$2.24 -$1.96 -$3.63 -$14.47
USD/shares -$1.72 -$1.75 -$2.24 -$1.96 -$3.63 -$14.47
shares 55.54M 52.13M 47.26M 44.4M 16.48M 3.66M
shares 55.54M 52.13M 47.26M 44.4M 16.48M 3.66M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Medical Devices median 2.38×
EV/EBIT
Medical Devices median 21.22×
P/E (TTM)
Medical Devices median 26.60×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
United States $270,378,000 $200,472,000 $124,297,000 $67,768,000 $28,948,000 $4,100,000
Non Us $37,676,000 $24,026,000 $11,894,000
Outside the United States $7,246,000 $5,525,000 $3,617,000
Key facts CIK 1588978 CUSIP 74276L105 13F (30d) 9 filings 8 filers Visit website Investor relations